Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source

被引：35
|
作者：
Su, Qiang [1 ]
Li, Qinghua [1 ]
机构：
[1] Guilin Med Univ, Affiliated Hosp, Guilin, Peoples R China
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 379卷 / 10期
关键词：
SYSTEMIC EMBOLISM; WARFARIN;
D O I：
10.1056/NEJMc1809065
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：986 / 986
页数：1
相关论文
共 50 条
  • [31] Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
    Torbjørn Wisløff
    Gunhild Hagen
    Marianne Klemp
    PharmacoEconomics, 2014, 32 : 601 - 612
  • [32] RIVAROXABAN IN PREVENTION OF STROKE IN ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Yavelov, I. S.
    KARDIOLOGIYA, 2019, 59 (12) : 4 - 11
  • [33] Structural heart intervention for prevention of embolic and hemorrhagic stroke: The new field of neurocardiology
    Morino, Yoshihiro
    Nakajima, Yoshifumi
    JOURNAL OF CARDIOLOGY, 2020, 76 (03) : 227 - 235
  • [34] Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting
    Morais, Joao
    Aguiar, Carlos
    McLeod, Euan
    Chatzitheofilou, Ismini
    Santos, Isabel Fonseca
    Pereira, Sonia
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2014, 33 (09) : 535 - 544
  • [35] Rivaroxaban for Stroke Prevention in East Asian Patients From the ROCKET AF Trial
    Wong, Ka Sing Lawrence
    Hu, Dai Yi
    Oomman, Abraham
    Tan, Ru-San
    Patel, Manesh R.
    Singer, Daniel E.
    Breithardt, Guenter
    Mahaffey, Kenneth W.
    Becker, Richard C.
    Califf, Robert
    Fox, Keith A. A.
    Berkowitz, Scott D.
    Hacke, Werner
    Hankey, Graeme J.
    STROKE, 2014, 45 (06) : 1739 - 1747
  • [36] Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke
    Ploen, Robert
    Sun, Li
    Zhou, Wei
    Heitmeier, Stefan
    Zorn, Markus
    Jenetzky, Ekkehart
    Veltkamp, Roland
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2014, 34 (03) : 495 - 501
  • [37] Protocol for AREST: Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation - A Randomized Controlled Trial of Early Anticoagulation After Acute Ischemic Stroke in Atrial Fibrillation
    Rose, David Z.
    Meriwether, John N.
    Fradley, Michael G.
    Renati, Swetha
    Martin, Ryan C.
    Kasprowicz, Thomas
    Patel, Aarti
    Mokin, Maxim
    Murtagh, Ryan
    Kip, Kevin
    Bozeman, Andrea C.
    McTigue, Tara
    Hilker, Nicholas
    Kirby, Bonnie
    Wick, Natasha
    Nhi Tran
    Burgin, W. Scott
    Labovitz, Arthur J.
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [38] Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation
    Skjoth, Flemming
    Larsen, Torben Bjerregaard
    Rasmussen, Lars Hvilsted
    Lip, Gregory Y. H.
    THROMBOSIS AND HAEMOSTASIS, 2014, 111 (05) : 981 - 988
  • [39] Rivaroxaban and other novel anticoagulants for stroke prevention in atrial fibrillation: time to embrace the future
    Rajappan, Kim
    HEART, 2013, 99 (06) : 361 - 362
  • [40] Rivaroxaban: A Review of its Use in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation
    Natalie J. Carter
    Greg L. Plosker
    Drugs, 2013, 73 : 715 - 739
12345